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Neurons define non-myelinated 
axon segments by the regulation 
of galectin-4-containing axon 
membrane domains
Natalia Díez-Revuelta1, Alonso M. Higuero1, Silvia Velasco1, María Peñas-de-la-Iglesia1,  
Hans-Joachim Gabius2 & José Abad-Rodríguez  1
The mechanism underlying selective myelination of axons versus dendrites or neuronal somata relies on 
the expression of somatodendritic membrane myelination inhibitors (i.e. JAM2). However, axons still 
present long unmyelinated segments proposed to contribute to axonal plasticity and higher order brain 
functions. Why these segments remain unmyelinated is still an unresolved issue. The bifunctional lectin 
galectin-4 (Gal-4) organizes the transport of axon glycoproteins by binding to N-acetyllactosamine 
(LacNac) termini of N-glycans. We have shown that Gal-4 is sorted to segmental domains (G4Ds) along 
the axon surface, reminiscent of these long unmyelinated axon segments in cortical neurons. We report 
here that oligodendrocytes (OLGs) do not deposit myelin on Gal-4 covered surfaces or myelinate axonal 
G4Ds. In addition, Gal-4 interacts and co-localizes in G4Ds with contactin-1, a marker of another type 
of non-myelinated segments, the nodes of Ranvier. Neither Gal-4 expression nor G4D dimensions 
are affected by myelin extracts or myelinating OLGs, but are reduced with neuron maturation. As in 
vitro, Gal-4 is consistently segregated from myelinated structures in the brain. Our data shape the 
novel concept that neurons establish axon membrane domains expressing Gal-4, the first inhibitor of 
myelination identified in axons, whose regulated boundaries delineate myelination-incompetent axon 
segments along development.
Axons are selectively myelinated while the somatodendritic membrane remains free of myelin insulation. 
Myelination does not require local stimulation or special geometric conditions, as surfaces of any shape can 
be myelinated in the absence of molecular inductors1,2. An explanation for this selective axon myelination has 
been recently reported, whereby the somatodendritic membrane expression of the Junction Adhesion Molecule 2 
(JAM2) inhibits local myelination3. Even though most axons are selected for myelination, they are not completely 
covered with myelin. The formation and significance of long unmyelinated axonal tracts, which have been related 
to high axonal plasticity underlying complex cognitive functions4, remain open questions.
The extensive complexity of glycan determinants and their dynamic changes are linked to key functions of the 
nervous system5–9, including those related with myelin structure. Glycoconjugates as myelin-associated glycopro-
tein (MAG), a sialic acid-binding lectin (Siglec-4a)10, gangliosides GD1a/GT1b or integrins play essential roles in 
internode stabilization. An illustrative example is contactin which is transported to myelinated axon paranodes 
as its N-glycans remain immature. Upon N-glycan maturation to their form bearing LacNAc termini, contactin 
is sorted to non-myelinated nodes of Ranvier, where it interacts with other glycosylated components (i.e. neuro-
fascin NF-186), and stabilizes the nodal structure11–13.
Importantly, the detection of glycan endogenous receptors (lectins) in the nervous system has prompted the 
idea of a functional glycan/lectin pairing14–17. In particular, the reported expression of members of the galectin 
family, tissue lectins with β-galactoside binding capacity18,19, has stimulated the research of their functional impli-
cations in nervous system physiology. So far, galectin-1 (Gal-1)20–24, galectin-3 (Gal-3)25,26, and galectin-4 (Gal-
4)27,28, have been related to axon growth and guidance, differentiation of microglia and oligodendrocytes, or nerve 
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regeneration. LacNAc-dependent sorting of contactin suggested the participation of galectin interactions in mye-
lin organization, according to our previous report of a directional Gal-4-based axon transport of LacNAc-bearing 
glycoproteins. In addition, Gal-4 is early sorted to the axon membrane, and it is expressed in discrete segments 
along axon surface of differentiated neurons28. The role of these membrane Gal-4-containing domains (G4Ds) is 
unknown, though their disposition in axons, reminiscent of non-myelinated segments of cortical neurons4,29, and 
the fact that soluble Gal-4 retards oligodendrocyte maturation27, prompted our hypothesis that Gal-4 in G4Ds 
could produce localized myelination impairment of functional consequences.
Here we identify Gal-4 as the first inhibitor of local myelination in axons, and propose that its expression in 
axon membrane domains defines myelination-incompetent axon segments regulated along neuronal development.
Results
Gal-4 is sorted to axon membrane domains in morphologically differentiated neurons. Gal-4 is 
enriched at the membrane of the nascent axon28, and is secreted by non-classical mechanisms to the extracellular 
milieu, where it keeps oligodendrocyte precursors (OLPs) in their undifferentiated proliferative state, unable to 
synthesize myelin27. As neurons progress through the different developmental stages30 in culture, the expressed 
lectin is sorted to discrete segments along the axonal plasma membrane, as represented by Gal-4 immunostain-
ing of non-permeabilized differentiated neurons with a morphologically distinguishable axon (stage 3) (Fig. 1a, 
arrowheads). Similarly, exogenously induced HA-tagged Gal-4 (Gal-4-HA) is also transported and targeted to 
axon membrane segments (Fig. 1b, arrowheads). When Gal-4-HA expression is induced in other cells of the 
nervous system that express very low levels of endogenous Gal-4, such as astrocytes, non-permeabilized immu-
nostaining for HA is observed as membrane “patches” (Fig. 1c, arrowheads). Importantly, our non-permeabiliz-
ing conditions only allow immunolabelling of Gal-4 at membrane outer leaflet, as neither intracellular proteins 
(GAPDH) nor cytosolic domains of transmembrane proteins (cadherins) were labelled under similar conditions 
(Supplementary Fig. S1). In addition, Gal-4 cannot be detected in conditioned media (CM) of differentiated 
neurons after 7 days in vitro (div) (Supplementary Fig. S2), minimizing the possibility of a significant impact of 
released galectin in our studies. Such a consistent mechanism for the formation and maintenance of G4Ds in 
axons suggested a potentially important role in neuronal physiology.
Myelinated axon segments express very low membrane Gal-4 levels. Considering that secreted Gal-4 
retards OLG maturation and myelin formation27, the segmented disposition of G4Ds suggested that Gal-4 could 
impede local myelination of those domains. To approach this question, we studied G4Ds in myelinating co-cultures 
of hippocampal neurons and OLGs, using myelin basic protein (MBP) labelling to assess OLG maturation. G4Ds 
were observed on axon membranes independently of eventual direct contact with non-myelinating OLGs. Figure 1d 
shows a representative image, evidencing that the portion of an axon growing on top of an immature OLG expresses 
strong membrane labelling for Gal-4 (Fig. 1d, arrowheads). In contrast, the initial contact points between differenti-
ated OLG extensions and axons are mostly devoid of Gal-4 (Fig. 1e, arrowheads). As co-cultures proceeded in time, 
longer axon segments appeared myelinated by fully mature OLGs, coinciding with the absence of axon membrane 
Gal-4 (Fig. 1f, arrowheads). After transforming confocal signal to show opaque surfaces (see methods for details), 
views from the top (Fig. 1f, Surface Top) and from the bottom (Fig. 1f, Surface Bottom) of the culture corroborate 
that the axon portion fully enwrapped by myelin (delimited by arrowheads) is practically devoid of Gal-4.
For quantification, membrane Gal-4 and MBP expression along the axon was measured as percentages of the 
maximum fluorescence intensity of each channel (Fig. 1g pictures and line graph). Taking in account that we con-
sidered that an axon segment is “myelinated” or “non-myelinated” when measured MBP fluorescence intensity is 
over 60% or below 30% of its maximum, respectively (please see methods for details), this analysis evidences that 
the average Gal-4 expression (Fig. 1g, bar graph) in non-myelinated axon segments is significantly higher (70%; 
black bar) than that of myelinated ones (25%; gray bar), in agreement with our qualitative observations.
Surface-bound Gal-4 repels myelin deposition. Co-culture experiments corroborated that G4Ds are 
essentially non-myelinated. However, they do not clarify whether it is Gal-4 itself, or any other component of those 
domains, that drive(s) myelin distribution along the axon. In order to test the direct contribution of bound Gal-4 to 
myelin distribution, we cultured OLGs on glass coverslips patterned with parallel alternated stripes, covered or not, 
with recombinant galectin. This display challenges OLGs to select the preferred surface to myelinate, resembling 
the situation they would find in co-cultures and likely in vivo. Fluorescein isothiocyanate (FITC) was used together 
with galectins or alone (control) to visualize the stripes (bright stripes). MBP-labelled areas in galectin-containing 
and galectin-free stripes were measured and compared as percentages of the total. After 7–9 div in culture, mature 
OLGs cultured on Gal-4-parallel stripes presented an irregular shape, suggesting a repulsive effect to myelin dep-
osition, which is preferentially spread on Gal-4-free surface (Fig. 2b, black stripes). In fact, 68.9% of myelin was 
formed on Gal-4-free stripes opposed to Gal-4-covered stripes (Fig. 2f, Gal-4), while 51.2% did when opposed to 
control FITC-covered stripes (Fig. 2a,f, FITC). Similar results to those of Gal-4 were obtained if stripes were cov-
ered with recombinant N-terminal domain of Gal-4 (Gal-4N, Fig. 2c). In this case, 64.6% of the myelin was formed 
on Gal-4N-free stripes (Fig. 2f, Gal-4N). In contrast, stripes covered with the recombinant C-terminal domain of 
Gal-4 (Gal-4C, Fig. 2d) did not trigger any effect, as 45.2% of the myelin was formed on Gal-4C-free stripes (Fig. 2f, 
Gal-4C). That bound Gal-4-induced inhibition of myelin formation is not a general feature of mammalian galectins 
is revealed by the lack of effect of full length Gal-3 (46.3% of myelin formed on galectin-free stripes; Fig. 2e,f, Gal3), 
although this does not exclude that other galectins could present a similar activity.
These results indicate that bound Gal-4 is capable to preclude myelin deposition by interaction with myelinat-
ing OLGs, and that this repulsive effect likely resides in Gal-4’s N-terminal domain. Although it cannot be ruled 
out that other G4D components could play a role in myelin organization along the axon, our data support that 
Gal-4 is a direct modulator of that process.
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Figure 1. Axonal G4Ds are not myelinated in neuron/oligodendrocyte co-cultures. (a) Hippocampal 
neurons (stage 3; 72 hiv) were immunolabelled for Gal-4 (red) without permeabilization. Gal-4 is detected 
in segments (arrowheads) along the axonal plasma membrane. (b) HA-tagged Gal-4 (Gal-4-HA) transfected 
hippocampal neurons were immunolabelled for HA (red) without permeabilization. Gal-4-HA is also detected 
in axon membrane segments (arrowheads). (c) Gal-4-HA transfected astrocytes were immunolabelled for HA 
(red) without permeabilization. Expressed Gal-4-HA forms “patches” on the cell surface (Gal-4-containing 
membrane domains; arrows). (d–g) Hippocampal neurons and oligodendrocytes were co-cultured for different 
time periods. The ICC for Gal-4 (red) was performed under non-permeabilizing conditions to detect Gal-4 
associated to axon surface. Cells were then permeabilized and immunolabelled for acetylated tubulin (blue) 
and MBP (green) to label axons and myelin, respectively. (d) The amount of Gal-4 associated to the axon 
membrane is not affected by the contact with oligodendrocytes at early stage of differentiation (arrowheads). 
(e) Axon points where initial contacts of myelinating oligodendrocytes occur are devoid of membrane Gal-4 
(arrowheads). (f) At more advanced stages of myelination in vitro, membrane Gal-4 is absent in myelinated 
axon segments (arrowheads). A 3D reconstruction from a stack of Z-planes processed to simulate opaque 
surfaces show that the myelin sheet (green) entirely wraps the portion of the axon devoid of Gal-4 (red) as 
seen from the top and bottom surfaces of the reconstructed image. (g) Membrane Gal-4 and MBP expression 
along the axon (dotted line in MBP picture depicts an example of axonal “region of interest” ROI), measured 
as percentages of the maximum fluorescence intensity in each channel, is plotted in the line graph (MBP green 
line, Gal-4 red line). Bar graph shows that average Gal-4 expression in non-myelinated axon segments (black 
bar) is significantly higher than that of myelinated ones (gray bar). Axon segments are considered “myelinated” 
when measured MBP fluorescence intensity is over 60% of its maximum, and “non-myelinated” when it is 
lower than 30% of the maximum (values are means + s.e.m. of 3 experiments, n = 38 and n = 35, respectively; 
*p < 0,001, two-tailed student’s t-test; scale bars 25 µm).
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Figure 2. Gal-4 covered substrates reject myelin deposition. (a–e) OLGs were allowed differentiate for 7–9 div 
on coverslips with parallel stripes covered with recombinant Gal-4, Gal-4N, Gal-4C and Gal-3. FITC (brighter 
stripes) was used together with galectins to evidence galectin-covered stripes (b–e), or alone as negative 
control (a). Cells were immunolabeled for MBP to visualize myelin. OLGs preferentially grow their myelinating 
processes on Gal-4-free (b) and Gal-4N-free (c) substrates, while Gal-4C does not produce any effect (d). The 
presence of Gal-3, used as control, does not affect myelin deposition (e). Quantitative analysis of the repulsive 
effect exerted by Gal-4 on mature OLGs is shown in (f). The bar graph shows the percentage of MBP-positive 
area on galectin-free stripes (covered with PLL alone). 50% indicates no preference of myelin deposition (no 
effect), while over and below 50% indicates inhibition and induction of myelin deposition, respectively (arrows 
in graph). Values are means +/− s.e.m. of three experiments (20 cells/experiment) (Gal-4 or Gal-4N vs FITC, 
Gal-4C or Gal-3; *p < 0.001, two-tailed, student’s t-test); (Scale bars 25 µm).
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The identification of G4Ds as non-myelinated axon domains suggested that they could concentrate glyco-
proteins normally found in non-myelinated nodes of Ranvier between myelinated internodes. Both in cultured 
hippocampal (Fig. 3a) and cortical (not shown) neurons, nodal glycosylphosphatidylinositol (GPI)-anchored 
glycoprotein contactin (Fig. 3a, arrowheads) extensively localize in G4Ds. To assess the interaction between 
Gal-4 and contactin, the rat pheochromocytoma cell line PC12 was used. These cells, frequently utilized as a 
“neuron-like” model, express both proteins and can N-glycosylate proteins to the final addition of LacNAc ter-
mini31. Using PC12 cell extracts, we show that anti-contactin antibodies co-immunoprecipitate Gal-4 (Fig. 3b, 
IP contactin WB Gal-4). Fittingly, the reverse experiment showed that Gal-4 antibodies co-immunoprecipitated 
contactin (Fig. 3b, IP Gal-4, WB contactin).
Gal-4/contactin co-localizations were observed in cultures of purified neurons. So it was still possible that 
such interactions would be altered by myelination. Immunocytochemical labelling of neuron/OLG co-cultures 
revealed that Gal-4 and contactin (Fig. 3c), colocalize in non-myelinated axon tracts. Those tracts in close contact 
with myelin, labelled with antibodies anti-MBP, were mostly devoid of Gal-4, and contactin (Fig. 3c, arrowheads). 
Gal-4 interaction with the nodal marker contactin, and its absence in myelinated segments, further support the 
notion that G4Ds are excluded from myelination and contribute to organize the discontinuous structure of mye-
lin along the axons.
Myelin does not affect G4Ds membrane display. Myelination is a dynamic process, thus final mye-
lin arrangement would require the variation of G4Ds dimensions and disposition. We hypothesized that the 
contact with myelin, as it expands laterally, could reduce G4Ds by inducing the elimination of Gal-4 from the 
axon membrane. To test this concept, 48 hours in vitro (hiv) hippocampal neurons were treated for different 
time periods with freshly prepared myelin extracts, and the levels of membrane Gal-4 were measured as average 
fluorescence intensity in immunolabelled cultures. Independently to the duration of the treatment or extract con-
centration (up to 24 hours and 12 μg total protein shown in Fig. 4a), no difference in Gal-4 membrane labelling 
was detected between treated and untreated cultures (Fig. 4a, bar graph). To further corroborate these results, 
identical treatments were applied to astrocytes induced to express Gal-4-HA (Fig. 4b). Similarly to neurons, 
Figure 3. Nodal marker contactin interacts and co-localizes with Gal-4 in non-myelinated axon segments. 
(a) Hippocampal neurons (stage 3; 72 hiv) were immunolabelled for Gal-4 (green) and contactin (blue) 
without permeabilization. Gal-4 and contactin colocalize in discrete segments (arrowheads) along the axonal 
plasma membrane. F-actin (red) was labelled with phalloidin to visualize neurons. (b) PC12 cell cultures 
were reversibly crosslinked, lysed, and protein extracts (Total ext.) were used to immunoprecipitate Gal-4 or 
contactin. The immunoprecipitated complexes were separated by SDS-PAGE and detected by WB. Recombinant 
Gal-4 (rec Gal-4), and incubations with protein-A or –G Sepharose beads in the absence of antibodies (Beads) 
were used as controls. Anti-Gal-4 precipitated contactin (IP-Gal-4, WB Contactin). Consistently, anti-contactin 
1 precipitated Gal-4 (IP Contactin, WB Gal-4), demonstrating the interaction of both proteins. Source full WBs 
are shown in Supplementary Fig. S5. (c) Hippocampal neurons and oligodendrocytes were co-cultured, fixed 
and analyzed by immunofluorescence. Labellings for Gal-4 (red) and contactin (blue) on axon membrane were 
performed under non-permeabilizing conditions. Cells were then permeabilized and immunolabelled for MBP 
(green) to visualize myelin. Myelinated axon segments present low levels of Gal-4 and contactin (arrowheads) 
(Scale bars 25 μm).
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Gal-4-HA membrane patches appeared unaffected by the treatment with myelin extracts, as fluorescence inten-
sity quantification showed non-significant differences with control cultures (Fig. 4b, bar graph). Even though 
the average Gal-4 content of the membrane was not affected by myelin extracts, it was still possible that its dis-
tribution could be altered. To check this, G4Ds lengths of myelin-treated neurons were measured and compared 
with controls. Myelin treatment did not change significantly the dimensions of G4Ds. In detail, average lengths 
in myelin-treated and non-treated cultures were 28.9 ± 0.84 μm and 28.4 ± 1,28 μm, respectively (Fig. 4c, upper 
graph). Nevertheless these results did not preclude the possibility of G4Ds modulation by myelin presented on 
OLG surface, in contrast to soluble extracts. To address this question, a parallel quantification of G4D length 
was performed in 21 div neurons co-cultured with myelinating OLGs for the last 7 div, and compared to that of 
control 21 div neurons. As for myelin extracts, no differences in G4D length due to myelinating OLGs could be 
detected (Fig. 4c, lower graph).
Neurons modulate Gal-4 expression and G4D size during axon development independently of 
myelin. Using Gal-4 display as read-out parameter, our results show that the contact with myelin does not 
modulate G4Ds on the axonal membrane, pointing to a neuronal control of those domains that could be mod-
ulated during axon development. Such a regulation would imply modifications of Gal-4/G4Ds with time in the 
absence of myelin or OLGs. To prove this we first followed Gal-4 membrane expression in hippocampal and cor-
tical neuron cultures with time. After 21 div, membrane Gal-4 mean fluorescence intensity is significantly reduced 
when compared to 3 div. In hippocampal neurons this reduction ranges 50% of the values at 3 div, while for 
cortical neurons it reaches 70%. Hippocampal neurons show a linear descending trend with constant decreases 
at 7, 14 and 21 div, while cortical neurons present a pronounced drop between 3 and 7 div, and slower decreases 
at 14 and 21 div (Fig. 4d,e, bar graphs on the left). These results correlate with the reduction trends of total Gal-4 
with time in culture measured by Western blot (WB) for both, hippocampal and cortical neurons (Fig. 4d,e, blots 
and bar graphs on the right). According to these data, the decrease of membrane Gal-4 with neuron maturation 
is due, at least in part, to a reduction of its expression rate, although these changes in Gal-4 expression do not 
necessarily imply modifications in G4Ds distribution or size. To check this we measured G4D length evolution 
with time in hippocampal and cortical neuron cultures (Fig. 4f,g). At 3 div G4D length is maximum, being longer 
in cortical (95.5 ± 6.8 μm) than in hippocampal (61.36 ± 4.1 μm) neurons, and covering in some cases most of 
the axon length. At 7 div an acute drop in G4D length occurs, reaching averages that range 30 μm in both neuron 
types. These values are maintained up to 14 div, to undergo a further significant decrease to approximately 20 
μm at 21 div (Fig. 4f,g, bar graphs). These results demonstrate that neurons can modulate axon membrane G4Ds 
along their development, independently of any interaction with OLGs or myelin.
Gal-4 and MBP (myelin) expression are segregated in rat brain cortex. According to our results 
in vitro, we hypothesized a negative correlation of Gal-4 and myelin expression in brain tissue. To corroborate 
this, immunohistochemical (IHC) labellings for Gal-4 and MBP were performed on vibratome slices of P3 and 
P30 rat brains (Fig. 5a). Previous reports27 showed by western blot (WB) that Gal-4 expression is high in P3 rat 
brains and decreases at P30 or later. The opposite was shown for MBP, whose expression is very low in P3 brain, 
while P30 brains express moderate quantities of the protein. In agreement with these results, MBP labelling in P3 
brain was fairly undetectable, while a descending gradient of MBP labelling was evident in P30 rat brains from the 
striatum to the cortex surface (Fig. 5b,c, red channel; 5D, black line; Supplementary Fig. S2). In contrast, Gal-4 is 
expressed in neurons of the cortical plate (CP) and layers IV/V of P3 brains (Fig. 5b, green channel), labelling the 
somata and fibres projecting to the brain surface (Fig. 5b, insets 1-2 arrowheads). In P30 brains Gal-4 labelling 
augments from deeper layer to the brain surface, and defines an inverted expression profile with respect to that of 
myelin (Fig. 5d and Supplementary Fig. S3, gray lines). Gal-4 levels at myelinated striatum and cortical layer VI 
are very low and restricted to somata (Fig. 5c, inset 4, green channel). At layers IV and V Gal-4 labelling is higher 
and localizes on neuronal somata and ascending fibres (Fig. 5c, insets 2-3, arrows and arrowheads, respectively), 
while at the outermost, scarcely myelinated layers I-III, Gal-4 expression is mostly confined to axon fibres (Fig. 5c, 
red channel; inset 1, arrowheads).
Considering the inverted expression profiles of Gal-4 and MBP (myelin) in brain cortex, we further explored 
the degree of co-localization of both molecules. Thresholded labels of Gal-4 and MBP channels were used to 
create maps of “positive particles” (defined as image particles >4.6 μm2 and <230 μm2 in area, with fluorescence 
intensities over a threshold, determined in each sample as the background fluorescence intensities measured in 
each channel, please see methods for details) as the ones shown for red and green channels of Fig. 5c (Fig. 5e, 
upper and central images). The combination of those maps showed that the number of co-localizing particles was 
significantly lower than those of Gal-4 or MBP (Fig. 5e, lower image and upper graph), and that their average area 
was significantly smaller than those of Gal-4 or MBP particles (Fig. 5e, lower graph). Of note, those quantifica-
tions were made using maximum projection of 38 confocal z-planes (1.3 μm step size, 50 μm z-volume) per brain 
section, thus part of those co-localized particles could be overestimated due to optical superposition. In fact, 
similar quantifications using single confocal z-planes of the same specimens showed proportionally fewer and 
smaller co-localizing particles when compared to Gal-4 or MBP particles (Supplementary Fig. S4).
In all, brain IHC studies confirm our results from in vitro experiments presented so far, and support the con-
cept that Gal-4 expression on neuronal membrane locally excludes the formation of myelin.
Discussion
OLGs require neither specific geometric conditions, nor inductive substrates to form myelin, indicating that 
selective myelination of axons is not due to the presence of local myelination inductors. On the contrary, recent 
studies have shown that the somatodendritic compartment of neurons is not myelinated due to the expression 
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Figure 4. Gal-4 expression and G4D dimensions are regulated along neuronal maturation independently 
of myelin. (a) Hippocampal neurons (48 hiv) and (B) Gal-4-HA-expressing astrocytes, treated for 24 hours 
with myelin extracts (+Myelin extract) or untreated (left panels in a and b), were immunolabelled without 
permeabilization for Gal-4 (a) and HA (b). The levels of membrane Gal-4 and Gal-4-HA were measured 
as average fluorescence intensity for neurons (bar graph in a) and astrocytes (bar graph in b), respectively. 
(c) G4Ds lengths of myelin-treated neurons (upper graph), and in co-cultures of neurons and myelinating 
OLGs (lower graph), were measured and compared with controls. No significant differences were observed 
for any of the measured parameters. (d,e) Hippocampal and cortical neurons were immunolabelled without 
permeabilization for Gal-4, and the average fluorescence intensity was measured (left bar graphs in d and e 
for hippocampal and cortical cultures, respectively). From 3 to 21 div, membrane Gal-4 mean fluorescence 
intensity significantly decreases. Upper right panels show representative WB for total Gal-4 expression in 
extracts of hippocampal (d) and cortical (e) neurons at different times in culture. GADPH was used as loading 
control (Source full WBs are shown in Supplementary Fig. S5). Lower right bar graphs in (d) and (e) display 
average Gal-4 densitometric measures referred to the minimum values at div 14, arbitrarily considered as 
1 in each case. Experiments were performed in triplicate. A significant reduction of total Gal-4 expression 
is observed between 3 and 14 div for both neuron types. Hippocampal (f) and cortical (g) neuron cultures 
were immunolabelled without permeabilization for Gal-4. The lengths of Gal-4 positive axon segments were 
measured in each condition. The bar graphs show acute drops in G4D length at 7 div, and slow decreases later 
on (n = 2951 for hippocampal neurons and n = 2148 for cortical neurons) (*p < 0.001, two tailed, student’s 
t-test). Experiments were replicated four times for each cell type. All bar graphs display means + s.e.m. (Scale 
bars 25 µm).
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on the membrane of a myelination inhibitor JAM2 which would explain why axons are selected for myelination. 
Nevertheless, axons are not completely myelinated, and the formation and function of long non-myelinated dis-
continuities along the axon are still unresolved issues.
We reported that differentiated neurons express Gal-4, a galectin that is specifically sorted to axon mem-
brane segments in a sulfatide-dependent manner. As documented here, exogenous HA-tagged Gal-4 expressed 
in neurons (Fig. 1b) displays the same pattern on the axon membrane than the endogenous Gal-4 (Fig. 1a), or 
is sorted to membrane “patches”, when expressed in astrocytes that express very low levels of endogenous Gal-4 
(Fig. 1c). This, and the fact that under our non-permeabilizing conditions, neither intracellular proteins nor 
cytosolic domains of transmembrane proteins can be detected (Supplementary Fig. S1), preclude the possibility 
of technical artifacts, and reinforces the concept of functional Gal-4-containing axon membrane domains.
Taking into account that Gal-4 secreted by immature neurons retards myelination by blocking the maturation 
of OLPs, and that G4D display along the axon are reminiscent of the non-myelinated axon segments of the outer 
neocortical layers, we hypothesized that Gal-4 could locally impair myelination of G4Ds, contributing to the for-
mation of non-myelinated axon tracts. In fact, myelinated portions of the axon are practically devoid of G4Ds, both 
at initial and at advanced myelination stages (Fig. 1e,f, Supplementary video), while these domains are not excluded 
from axon contacts with pre-myelinating OLPs (Fig. 1d). Whether Gal-4 was directly responsible for G4Ds exclu-
sion from myelinated segments remained obscure. Unfortunately, knocking-down Gal-4 by interference RNA was 
Figure 5. Gal-4 distribution along the brain cortex inversely correlates with myelin. (a) Low-magnification 
photomicrograph of a P3 (left) and P30 (right) rat cerebral hemisphere stained with Hoechst. White boxes 
indicate the regions within the somatosensory cortex shown in b and c. (Scale bars 500 µm). Maximum 
intensity projections of confocal mosaic stacks obtained from a P3 (b) and P30 (c) rat cortex. The sections were 
immunolabeled for MBP (red) and Gal-4 (green). Nuclei were stained with Hoechst (blue). Numbered boxes 
(1–4) representing different cortical depths are shown at higher magnification in the bottom images. Note the 
greater expression of Gal-4 in the upper layers (boxes 1 and 2) compared to the bottom layers (boxes 3 and 4), 
both at P3 and P30. Gal-4 is present in fibers (arrowheads) as well as cell bodies in the upper layers, while its 
expression is largely confined to cell bodies at bottom layers (boxes 3 and 4, arrows in c). (Scale bars 100 µm). 
(d) MBP and Gal-4 fluorescence intensities were measured from the pia to the white matter of P30 rat brain 
cortices (n = 5). Profiles were plotted and the values normalized to the maximal intensity obtained for each 
channel (profiles for the P30 cortex in c are shown here, all profiles are available in Supplementary Fig. S3). Note 
that in deeper cortical layers (VI) the intensity for MBP is maximal while Gal-4 displays its lowest levels. On 
the contrary, the upper scarcely myelinated layers (I-III) show abundant Gal-4 fluorescent intensity. (e) MBP 
and Gal-4 positive particle maps from the samples used in D, were analyzed to determine their degree of co-
localization (those from the P30 cortex in c are shown in the upper and central images, co-localizing particle 
map is shown in the lower image). Quantification of average number and area of co-localizing particles in the 
bar graphs below (black bars), indicate that co-localization level is low, and that the average size of co-localizing 
particles is significantly smaller compared to Gal-4 (gray bars) or MBP (pale gray bars) particles (values are 
means + s.e.m.; n = 5; *p < 0,001, two-tailed student’s t-test).
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not appropriate to approach this issue because low level of Gal-4 significantly retards axon growth, as we previously 
shown. Alternatively, cell culture surfaces with parallel microstripes, covered or not with recombinant Gal-4, were 
suited to mimic the scenario in which OLGs are challenged to myelinate G4Ds or Gal-4-free axon segments. Under 
such conditions, OLGs preferentially myelinated Gal-4-free stripes (Fig. 2b,f). Moreover, recombinant N-terminal 
domain of Gal-4 was sufficient to preclude myelin deposition (Fig. 2c,f). In consequence, it appears that Gal-4 
presence is sufficient to keep myelination excluded from G4Ds, conferring functional significance to these domains.
The bivalent Gal-4 is capable to bridge glycans in a rather stable manner, stabilizing/organizing “superrafts” 
and yielding vesicle aggregation, proof for the concept of higher-order microdomain formation32–34. We show 
here that Gal-4 within G4Ds co-localizes and interacts with contactin (Fig. 3), whose N-glycans need to acquire 
complex LacNAc termini for a correct targeting to nodes of Ranvier. The fact that Gal-4 has strong binding affinity 
for LacNAc presented in clusters35–38, could underlie contactin recruitment to myelin-excluding G4Ds. It would 
be important to investigate whether contactin localization is changed in Gal-4-deficient conditions, and how 
this affects myelination. In principle, as Gal-4 axonal sorting depends on sulfatides, pharmacological inhibition 
of sulfation in neuron/OLGs co-cultures by sodium chlorate could help to answer this question. Unfortunately, 
sulfation inhibition not only affects neurons, it deeply impacts OLG cytoarchitecture and myelination capacity39, 
making difficult to obtain accurate mechanistic information in this way, and pointing to the need of experimental 
systems designed to induce sulfatide modification either in neurons or in OLGs.
The idea that MBP labelling (myelin) is absent on Gal-4-expressing neuron membrane, and that this is main-
tained at different developmental stages, is strongly supported by comparison of the expression profiles of both mol-
ecules in brain tissue. At P3, when myelination is beginning, Gal-4 is present in neurons of the CP and developing 
layers IV and V (upper part), but not in layer VI or striatum, two zones that will become heavily myelinated later on 
(Fig. 5b). Consistently, when myelination is quite advanced, as shown in P30 brains, barely myelinated layers II-III, 
and layers IV-V maintain different patterns of Gal-4 expression, while myelinated layer VI and striatum show very 
low expression of the galectin (Fig. 5c, Supplementary Fig. S3). Those inverted Gal-4 and MBP expression profiles 
along the axis from white matter to brain surface (Fig. 5d, Supplementary Fig. S3), are consistent with the almost 
complete segregation of Gal-4- and MBP-labelled sub-cellular structures, evidenced by co-localization analyses 
(Fig. 5e; Supplementary Fig. S4). The analysis of brain tissue thus reinforces the conclusion obtained in vitro that 
Gal-4 excludes myelin deposition, pointing to a functional role in the developmental organization of myelin.
Axon myelination proceeds by lateral expansion of the concentric myelin sheaths until myelin configuration 
is established, with myelinated segments (internodes) separated by nodes of Ranvier or by the recently reported 
long non-myelinated tracts in cortical layers I-III. In either way, final myelin arrangement would require shrink-
age of G4Ds and/or changes in their disposition along the axon. We first thought that myelinating OLGs could 
modulate this process, and proposed that the contact of myelin with one or more G4D components would induce 
the elimination of Gal-4 (and probably other molecules) from the axon surface through the activation of local 
endo/exocytosis. However, no changes in G4D quantity or dimensions were observed in axons exposed to myelin 
extracts (Fig. 4a,c upper graph). Importantly, G4Ds were neither affected by myelinating OLGs (Fig. 4c, lower 
graph), which precludes the possibility that G4D modulation could depend on myelin presentation on the OLG 
surface. In all these results pointed to a myelin-independent neuronal regulation of these domains with neuron 
differentiation. In support of this hypothesis, total Gal-4 expression in hippocampal and cortical neurons signif-
icantly decreases with time in culture, which is reflected by a concomitant reduction of the amount of galectin 
detected on neuronal membranes (Fig. 4d,e). In addition, G4Ds become shorter as neurons mature in the absence 
of any contact with myelin (Fig. 4f,g), indicating that the arrangement of these domains, which influences myelin 
deposition, is regulated by neurons. It is important to note that the highest values of Gal-4 expression and of G4Ds 
average length in cultured neurons correspond to the fast axon growth period (up to 3 div), when low myelination 
must be maintained in order to allow the efficient elongation of the axons. Within the next five div, Gal-4 expres-
sion undergoes a severe reduction and, from that time point on, G4Ds continue a further slow-rate shortening, in 
coincidence with the time period when myelination actively progresses.
Furthermore, spontaneous synaptic activity increases with neuron differentiation in a time pattern similar to 
that observed for G4D variation. In cultures of dissociated neocortical neurons the number of spiking neurons aug-
ment significantly between 6 and 15 div40. That neuronal activity regulates CNS myelination is widely accepted41–43, 
and the local signalling mediated by axon synaptic vesicle release effect on OLGs, has been proposed as an impor-
tant mechanism for this regulation44–46. Considering the contemporary variations of G4Ds and spontaneous syn-
aptic activity in cultured neurons, it is appealing to speculate that, independently of OLGs, changes in spontaneous 
synaptic release could drive the modifications of Gal-4 and G4Ds that organize axon membrane for myelination. 
This would be compatible with the activation of OLGs by synaptic vesicle release mentioned above. The presented 
results and arising reasoning give further research into this question a clear direction. In the broad context, this 
work has potential to underscore the significance of concerted interplay between tissue lectins and cellular glyco-
conjugates by functional pairing, a key route to turn glycan-encoded information into functionality47–50.
Methods
Antibodies. The following antibodies were used: acetylated α-tubulin (T6793, clone 6-11B-1; Sigma) and 
βIII-tubulin (Tuj1, T8578, clone 2G10; Sigma), MBP (ab7349; Abcam), HA (11867431001, clone 3F10; Roche), 
contactin 1 (sc-20296; Santa Cruz Biotechnology). Rabbit polyclonals anti-Gal-4 and anti-Gal-3 (in-house pro-
duction) were purified by affinity chromatography-based depletion, using the respective galectin as bead-im-
mobilized ligand, and further tested by means of ELISA screening and Western blot against other commonly 
expressed members of this family, i.e. galectins-1, -2, -7, -8, and -9, to exclude cross-reactivity51. F-actin was 
detected with TRITC- or FITC-conjugated phalloidin (P1951 and p5282, respectively, Sigma). Appropriate flu-
orescent anti-species secondary antibodies were from Invitrogen (A21202; A21203; A21206; A21207; A11055; 
A11058; A31571; A31573).
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Recombinant galectins. Human galectin-4 (Gal-4) and its two separate carbohydrate recognition domains 
corresponding to a.a.1–150 and 176–323, referred to as N- and C-terminal domains (Gal-4N/C), respectively, 
were obtained by recombinant production, purified by affinity chromatography on lactosylated Sepharose 4B, and 
controlled for purity by 1D- and 2D-gel electrophoresis and mass spectrometry, and for activity by solid-phase 
and cell binding assays35,52,53.
Cell cultures. Rat hippocampal and cortical neurons, primary astrocytes and PC12 cells were cultured as 
described previously28. Primary OLG cultures were prepared from the neocortex of 1–3-day-old rats, as pre-
viously described54. The purified OLGs were maintained in serum-free growth medium consisting of DMEM/
Ham’s F12 (Gibco) (1:1) containing sodium selenite (30 nmol/l), putrescine (1 mg/l), insulin (5 mg/l), hydrocor-
tisone (20 nmol/l), progesterone (20 nmol/l), transferrin (25 mg/l), biotin (10 nmol/l), 3,3′,5-triiodo-L-tyronine 
(30 nmol/l), bovine serum albumin (BSA 1 mg/ml), supplemented with PDGFAA (5 ng/ml) and bFGF (10 ng/ml) 
for 48 h. Cells were then allowed to mature by growth factor withdrawal.
Neuron/oligodendrocyte co-cultures were performed as previously described by Gardner and collaborators55 
with some modifications. Oligodendrocyte were seeded onto 7 div cultured neurons, and cultured in MEM-HS 
and serum-free OLG growth medium in a 3:1 ratio. OLG medium proportion was gradually increased every 3 
days by adding 1 ml each time. After 17 days of co-culture, cells were fixed and analysed by ICC.
Neuron-free myelination assay on galectin-stripped carpets. Substrate-challenge assays were set up 
by coating the surface of glass coverslips with recombinant Gal-4, Gal-4N, Gal-4C, and Gal-3 in parallel stripes. 
Silicon matrices with parallel micro-channels were used as described previously56. Briefly, solutions containing the 
Gal-4 proteins (1 mg/ml) and FITC (1 µg/ml; Sigma-Aldrich) were injected into the matrices and incubated for 
three hours at room temperature. Striped substrata covered with FITC alone were used as controls. Oligodendrocyte 
precursors were seeded and cultured for 12 hours at 37 °C in proliferation medium, and cultured for further 7–9 
div after growth factor withdrawal. Cells were then fixed and analyzed by ICC. Myelin total area and myelin area on 
galectin-free substrates (PLL lines) were manually delimited using the “Polygon Selection” tool, stored in the regions 
of interest (ROI) manager, and measured using the “Analyze Area” tool of ImageJ software (NIH).
For ICC analysis, cells were fixed with 4% paraformaldehyde for 15 minutes at RT, aldehyde groups were 
quenched with 50 mM ammonium chloride for 5 minutes. When indicated, membranes were permeabilized with 
0.1% Triton X-100 in PBS during 5 minutes (permeabilized condition), if not, the permeabilization step was 
omitted (non-permeabilized condition). Cells were incubated in blocking solution (2% FBS, 2% BSA, 0.2% gelatin 
in PBS) for one hour, followed by incubation with primary antibodies for one hour at RT or overnight at 4 °C. 
After extensive washing, cells were incubated with appropriate secondary antibodies for one hour. For simulta-
neous detection of neuronal membrane-associated Gal-4, MBP and/or acetylated α-tubulin, a first ICC for Gal-4 
detection was performed under non-permeabilizing conditions. Cells were then fixed again, permeabilized, and 
a second ICC was performed to detect MBP and/or acetylated α-tubulin. Coverslips were then mounted on glass 
slides with Mowiol (Calbiochem) using DABCO (Sigma) as anti-fade agent. Images were acquired on a confocal 
microscope (Leica SP5) or/and an epifluorescence microscope (Leica DM5000B).
Cell extracts and Western blotting. Total cell extracts for biochemical analysis were obtained from hip-
pocampal and cortical neurons cultures at high cell density. Cells were lysed for 20 minutes at 4 °C in RIPA-buffer 
(25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) supplemented with 
protease inhibitors (Sigma). Protein extracts were centrifuged for 15 minutes at 13,000 rpm at 4 °C. Supernatants 
were considered as total extracts. Protein concentration was quantified by the bicinchoninic acid assay (BCA; 
Bio-Rad).
Cross-linking and immunoprecipitation. For cross-linking assays, PC12 cell extracts were incubated 
with the reversible homobifunctional cross-linker dithiobis(succinimidylpropionate) (DSP; Pierce), following the 
manufacturer’s instructions. Reaction was quenched with Tris buffer (pH 7.5), and cells were scraped in cold lysis 
buffer (PBS, 5 mM EDTA, 0.5% Triton X-100). Protein extracts were centrifuged for 15 minutes at 13,000 rpm at 
4 °C. Supernatants were incubated with anti-Gal-4 or anti-contactin 1 antibodies at 4 °C for 18 hours, and then 
complexes were bound to protein-A- or protein-G-Sepharose. The immunoprecipitated complexes were sepa-
rated by SDS-PAGE and subjected to detection by WB for contactin 1 or Gal-4.
Gal-4-HA expression. HA-tagged Gal-4 expression vector was prepared by insertion of the human Gal-4 
cDNA into the pcDNA3.1(+)_HA vector (Invitrogen). Astrocytes or neurons were transfected in suspension using 
the Nucleofector system (Amaxa) according to the manufacturer’s instructions. 48/72 hours post-nucleofection, 
cells were harvested and processed for biochemical analysis, or fixed for ICC and morphological evaluation.
Myelin extracts. Myelin extracts were prepared from optic and sciatic nerves from adult rats57. Nerves were 
freed from blood vessels and connective tissue in PBS, and lysed by a glass-teflon homogeinizer in homogeniza-
tion buffer (20 mM Hepes-NaOH, pH 7.5) supplemented with protease inhibitors. Tissue extract was centrifuged 
for 3 minutes at 3,000 rpm at 4 °C. Supernatant were considered as total extracts, and was centrifuged again on a 
Beckmann ultracentrifuge for 20 minutes at 20,000 rpm at 4 °C. Membrane pellets were then extracted in 300 µl of 
buffer and, this solution then loaded on a sucrose-step gradient (300 µl of 0.8 M; 300 µl of 1 M; 100 µl of 1.2 M sucrose 
in buffer) and centrifuged for 1 hour at 42,000 rpm. Myelin was removed from the band above the 0.8 M sucrose, 
re-suspended in buffer with protease inhibitors, and centrifuged on a desktop centrifuge to remove the remaining 
sucrose. Pellet was re-suspended in buffer without protease inhibitors for further use and analysed by WB.
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Quantification of G4Ds. Neuron cultures or neuron/OLG co-cultures were fixed at different div and immu-
nostained for Gal-4 in non-permeabilizing conditions. After permeabilization, axons were immunostained for 
Tuj1, and OLGs/myelin were labelled for MBP. Images of twenty fields per condition were obtained under identi-
cal microscope settings, and Gal-4 fluorescence intensity in neuron cultures was measured using ImageJ software. 
Gal-4-positive segments were manually traced, and their lengths were measured using the NeuronJ plugin for 
ImageJ software.
To quantify the extent of coincidence between MBP (myelinated) and Gal-4-containing axon segments, 
Gal-4 and MBP fluorescence intensities were measured along single axons in microscope images of neuron/
OLG co-cultures. Clearly visible axon portions were selected, and ROIs were created by tracing the axons with 
the “add trace” tool of the “NeuronJ” plugin (ImageJ software). “Plot profile” tool was then applied to these ROIs 
obtaining distance/intensity value sets for each channel. Intensity values were standardized as percentage of the 
maximum fluorescence intensity in each channel, and plotted versus the distance from the origin. Axon seg-
ments were considered “myelinated” when average MBP fluorescence intensity was over 60% of its maximum, 
and “non-myelinated” when it remained below 30% of the maximum. Average Gal-4 fluorescence intensity per-
centages in non-myelinated (n = 38) and myelinated (n = 35) axon segments were calculated and compared by 
two-tailed student’s t-test.
Immunohistochemistry and co-localization analyses. Postnatal 3 and 30 days old Wistar rats (P3 and 
P30) were deeply anesthetized and transcardially perfused with saline followed by fixative solution of 4% para-
formaldehyde (PFA). Brains were dissected out, post-fixed during 2 hours at RT, washed with phosphate buffer 
(0.2 M PB, pH 7.4), and 50 μm thick coronal tissue sections were obtained with a vibrating-blade microtome 
(Leica VT1000S).
For IHC analysis, free-floating sections were blocked with PBS containing 2% BSA, 8% donkey serum and 
0.2% Triton X-100 (blocking solution) for 1 hour at RT, and incubated with primary antibodies o/n at 4 °C in 
diluted blocking solution (1:3). After extensive washing, sections were incubated with secondary antibodies 
for 90 min, thoroughly washed, and mounted with Mowiol-DABCO. Equivalent sections of both P3 and P30 
brains were selected, and mosaic images spanning the entire somatosensory cortex layers up to the striatum were 
acquired on a confocal microscope (Leica SP5; 40X oil-immersion objective, one plane was acquired each 1,3 
microns in depth, to a total of 38 z-planes per brain section).
Average fluorescence intensities of Gal-4 and MBP channels were measured along the entire columns from 
cortical layer VI to brain surface. Single-channel images were opened with the ImageJ software (version 1.49e; 
NIH USA), and rectangular ROIs covering the full images were created. “Plot profile” tool was then applied to 
these ROIs obtaining distance/intensity value sets for each channel. Intensity values were standardized as per-
centage of the maximum fluorescence intensity in each channel, and plotted versus the distance from the bottom.
For co-localization analyses, Gal-4 and MBP channels from maximum projections (Fig. 5e) or single z-plane 
confocal images (Supplementary Fig. S4) were converted to gray scale images (8 bit, 118 pixels/cm), and thresh-
olded using the Image/adjust/threshold tool of the ImageJ software. The threshold was determined in each sample 
as the background fluorescence intensity measured for each channel. A set of co-localizing particle maps was 
obtained by applying the co-localization plugin (ImageJ) to thresholded Gal-4 and MBP images simultaneously. 
Numbers and areas of Gal-4, MBP and co-localized particles were obtained using the particle analysis plugin 
(ImageJ; particle size settings between 6 and 300 pixels2, equivalent to 4, 6 and 230 μm2, respectively). Means 
and s.e.m. (n = 5) were calculated for each parameter, and results were statistically compared using two-tailed 
student’s t-test.
All procedures involving animals complied with international guidelines on the ethical use of animals in 
the European Communities Council Directive dated 24 November 1986 (86/6091EEC). The Institutional Ethics 
Committee of the Sanitary Area of Toledo (CEIC) has approved the experimental procedures included in this 
work (certificate ref CEIC 95; 2016/07/14).
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